Advanced Micro and Nano Drug Delivery Systems Designed for Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (20 January 2023) | Viewed by 29285
Special Issue Editors
Interests: drug delivery; cancer therapy; crystallization; encapsulation; nanoparticles; triggered release; biopolymers
Interests: biomaterials; microcontainers; nanoparticles; encapsulation; drug delivery
Interests: biomedical materials; physiology; drug encapsulation; drug release; drug delivery; coatings; lamination; ultrasound; thin films; tissue engineering; cell proliferation
Special Issue Information
Dear Colleagues,
The latest advances in nanomedicine are aimed at targeted delivery of drugs to tumor foci after intravenous administration with the possibility of avoiding excessive accumulation of toxic drugs in normal tissue. The recent successful application of nanostructured particles as delivery vehicles has demonstrated the superior potential of nanostructure-based technology for drug delivery in biomedicine.
This Special Issue addresses the multidisciplinary field and aims to discuss innovative advances in the design and applications of nanostructured systems for cancer diagnosis, imaging, and therapy. We invite authors to report their recently developed inorganic, organic, and composite nano/microparticles for the delivery of anticancer drugs, photosensitizers, siRNA, etc.
Dr. Daria Trushina
Dr. Alexey Ermakov
Dr. Olga Sindeeva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nano-/microparticles
- polymer carriers
- drug delivery
- imaging
- biomedicine
- tumor targeting
- photodynamic therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.